AUD 3.05
(54.04%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 | 118.92 Million USD | 2.08% |
2023 | 116.49 Million USD | 8.97% |
2022 | 106.9 Million USD | 1.34% |
2021 | 105.49 Million USD | 6.22% |
2020 | 99.31 Million USD | 22.18% |
2019 | 81.28 Million USD | 36.85% |
2018 | 59.39 Million USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 119.14 Million USD | 2.28% |
2024 FY | 118.92 Million USD | 2.08% |
2024 Q4 | 118.92 Million USD | 0.0% |
2024 Q2 | 121.99 Million USD | 2.39% |
2023 Q2 | 111.78 Million USD | 1.96% |
2023 Q4 | 116.49 Million USD | 1.65% |
2023 FY | 116.49 Million USD | 8.97% |
2023 Q3 | 114.6 Million USD | 2.53% |
2023 Q1 | 109.63 Million USD | 2.55% |
2022 Q2 | 103.17 Million USD | -3.75% |
2022 Q1 | 107.19 Million USD | 1.61% |
2022 Q3 | 104.65 Million USD | 1.43% |
2022 Q4 | 106.9 Million USD | 2.15% |
2022 FY | 106.9 Million USD | 1.34% |
2021 Q3 | 101.84 Million USD | 2.12% |
2021 FY | 105.49 Million USD | 6.22% |
2021 Q1 | 101.02 Million USD | 1.72% |
2021 Q2 | 99.72 Million USD | -1.29% |
2021 Q4 | 105.49 Million USD | 3.59% |
2020 Q1 | 89.17 Million USD | 9.7% |
2020 Q2 | 94.29 Million USD | 5.75% |
2020 Q3 | 95.77 Million USD | 1.56% |
2020 Q4 | 99.31 Million USD | 3.7% |
2020 FY | 99.31 Million USD | 22.18% |
2019 Q4 | 81.28 Million USD | 2.15% |
2019 Q3 | 79.57 Million USD | 25.35% |
2019 Q2 | 63.48 Million USD | 3.8% |
2019 Q1 | 61.15 Million USD | 2.97% |
2019 FY | 81.28 Million USD | 36.85% |
2018 Q4 | 59.39 Million USD | 89.03% |
2018 FY | 59.39 Million USD | 0.0% |
2018 Q3 | 31.42 Million USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2005 FY | - USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
EZZ Life Science Holdings Limited | 123.85 Thousand AUD | -95917.149% |
Anatara Lifesciences Ltd | - AUD | -Infinity% |
Zelira Therapeutics Limited | 5.65 Million AUD | -2003.532% |
Biome Australia Limited | 1.3 Million AUD | -9007.856% |
Patrys Limited | - AUD | -Infinity% |
Orthocell Limited | 689.69 Thousand AUD | -17142.889% |
Imugene Limited | 1.54 Million AUD | -7587.693% |
Noxopharm Limited | - AUD | -Infinity% |
PYC Therapeutics Limited | 1.11 Million AUD | -10586.903% |
Chimeric Therapeutics Limited | - AUD | -Infinity% |
Prescient Therapeutics Limited | 330.48 Thousand AUD | -35884.278% |
Proteomics International Laboratories Limited | 316.39 Thousand AUD | -37486.877% |
Cynata Therapeutics Limited | - AUD | -Infinity% |
CSL Limited | 18.24 Billion AUD | 99.348% |
Arovella Therapeutics Limited | - AUD | -Infinity% |
Bio-Gene Technology Limited | - AUD | -Infinity% |
Clinuvel Pharmaceuticals Limited | 879.78 Thousand AUD | -13417.295% |
Starpharma Holdings Limited | 3.52 Million AUD | -3270.833% |
Nanollose Limited | 42.53 Thousand AUD | -279521.444% |
Memphasys Limited | 4.41 Million AUD | -2594.727% |
Invex Therapeutics Ltd | - AUD | -Infinity% |
NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
Amplia Therapeutics Limited | 1.56 Million AUD | -7514.878% |
Botanix Pharmaceuticals Limited | - AUD | -Infinity% |
Island Pharmaceuticals Limited | 421.96 Thousand AUD | -28082.943% |
Race Oncology Limited | - AUD | -Infinity% |
Nyrada Inc. | - AUD | -Infinity% |
Telix Pharmaceuticals Limited | 17.44 Million AUD | -581.702% |
Dimerix Limited | 149.68 Thousand AUD | -79349.904% |
PharmAust Limited | - AUD | -Infinity% |
Immutep Limited | 1.22 Million AUD | -9582.17% |
Clarity Pharmaceuticals Ltd | - AUD | -Infinity% |
Alterity Therapeutics Limited | 159.04 Thousand AUD | -74673.177% |
BTC Health Limited | - AUD | -Infinity% |
Acrux Limited | 1.48 Million AUD | -7897.512% |
Neuren Pharmaceuticals Limited | - AUD | -Infinity% |
Biotron Limited | 7130.00 AUD | -1667824.264% |
Tissue Repair Ltd | - AUD | -Infinity% |
AdAlta Limited | 2.49 Million AUD | -4667.297% |
Radiopharm Theranostics Limited | - AUD | -Infinity% |
Hexima Limited | - AUD | -Infinity% |
AnteoTech Limited | 23.59 Thousand AUD | -503981.892% |
Paradigm Biopharmaceuticals Limited | 239.33 Thousand AUD | -49589.968% |
Recce Pharmaceuticals Ltd | 811.19 Thousand AUD | -14560.314% |
Avecho Biotechnology Limited | 175.15 Thousand AUD | -67797.414% |
Actinogen Medical Limited | 319.06 Thousand AUD | -37171.875% |
Immuron Limited | 173.49 Thousand AUD | -68444.701% |
Argenica Therapeutics Limited | - AUD | -Infinity% |